Results 191 to 200 of about 99,547,245 (298)

Oral lichenoid lesions in CTLA-4 haploinsufficiency: Targeting IFN-γ-driven mucosal immunopathology. [PDF]

open access: yesJ Eur Acad Dermatol Venereol
Wang C   +11 more
europepmc   +1 more source

Determinants of T Cell Exhaustion: How Far Back Can We Go?

open access: yesImmunology, EarlyView.
Classical versus Emerging models of CD8+ T Cell Exhaustion. Comparison of the classical ‘Endpoint Model’ (Left), where exhaustion is viewed as a terminal state requiring reversal, versus the emerging ‘Trajectory Model’ (Right). Recent studies suggest exhaustion is a continuous developmental path initiated early in infection or tumuorigenesis ...
Testimony Olumade   +2 more
wiley   +1 more source

Five‐year survival impact of adjuvant anti‐PD‐1 therapy in a nationwide cohort of stage III melanoma

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This nationwide real‐world cohort study was unable to demonstrate a population‐level survival benefit of adjuvant anti‐PD‐1 in stage III melanoma. Matched analyses suggested higher OS in treated patients. However, limited statistical power and potential residual confounding preclude firm conclusions.
Marie B. Weitemeyer   +11 more
wiley   +1 more source

Design and Characterization of Prodrugged Anti-CTLA-4 Antibodies. [PDF]

open access: yesChembiochem
Yamazoe S   +15 more
europepmc   +1 more source

Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Durvalumab plus tremelimumab (Dur/Tre) has shown promising efficacy in advanced hepatocellular carcinoma (HCC), but predictive biomarkers remain unclear. This study aimed to determine whether early changes in peripheral blood lymphocyte counts during Dur/Tre therapy can predict clinical outcomes.
Yuichi Honma   +36 more
wiley   +1 more source

Caregivers in a Haystack? Informatics‐Driven Clinical Trial Enrollment of Dementia Caregivers at Medical Visits

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Caregiving status is not routinely documented during clinical care, rendering caregivers difficult to identify for research and supportive interventions. We describe two informatics‐based strategies for identifying dementia caregivers at their own or their care recipient's point of care (POC).
Eva S. Ren   +11 more
wiley   +1 more source

Complete Regression of bilateral Choroidal Metastases secondary to a Cutaneous Melanoma under Immunotherapy

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Yenny Angela   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy